Introduction
| Dorsal Motor Nucleus of Vagus in Parkinson Disease | |
|---|---|
| **Category** | Autonomic Nervous System |
| **Location** | Medulla oblongata, dorsal vagal complex |
| **Cell Type** | Preganglionic parasympathetic neurons |
| **Neurotransmitter** | Acetylcholine |
| **Function** | Parasympathetic regulation of viscera |
| **Cranial Nerve** | CN X (Vagus nerve) |
| Taxonomy | ID |
| Cell Ontology (CL) | [CL:0000100](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000100) |
| Database | ID |
| Cell Ontology | [CL:0000100](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000100) |
| Target | Pathway |
| **Heart** | Cardiac branches |
| **Lungs** | Pulmonary branches |
| **Stomach** | Anterior/posterior vagal trunks |
| **Intestine** | Enteric nerves |
| **Pancreas** | Pancreatic branches |
| **Liver** | Hepatic branches |
| Symptom | Prevalence |
| **Constipation** | 50-80% |
| **Orthostatic hypotension** | 30-50% |
| **Urinary dysfunction** | 40-70% |
| **Gastroparesis** | 30-50% |
| **Excessive salivation** | 30-70% |
| Approach | Target |
| **Deep brain stimulation** | Not typically DMV |
| **Vagus nerve stimulation** | DMV |
| **L-DOPA** | Nigrostriatal |
| **Alpha-synuclein immunotherapy** | Pathology |
| Model | Features |
| **α-syn overexpression mice** | GI pathology |
| **MPTP model** | Autonomic dysfunction |
| **6-OHDA model** | Vagal lesions |
| **Transgenic α-syn rats** | Lewy body-like pathology |
Dorsal Motor Nucleus Of Vagus In Parkinson Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
Overview
1Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with normal cognition, mild cognitive impairment, and Alzheimer's diseaseOpen referenceMulti-Taxonomy Classification
Taxonomy Database Cross-References
Morphology & Electrophysiology
-
Morphology: motor neuron (source: Cell Ontology)
-
Morphology can be inferred from Cell Ontology classification
-
PanglaoDB Marker Cross-References
-
Unknown (PanglaoDB):
External Database Links
Taxonomy & Classification
PanglaoDB Marker Cross-References
-
Unknown (PanglaoDB):
External Database Links
Anatomical Organization
Location and Structure
-
Position: Dorsal medulla, caudal to the obex
-
Subnuclear organization: Cardio-pulmonary and gastrointestinal divisions
-
Neuronal morphology: Small to medium-sized cholinergic neurons
-
Projections: Via vagus nerve to postganglionic neurons in target organs
Connectivity
Normal DMV Function
Parasympathetic Regulation
-
Rest and digest: Activation during relaxed states
-
GI motility: Coordinated peristalsis via enteric nervous system
-
Gastric secretions: Acid, enzyme release
-
Heart rate: Vagal tone reduces heart rate
-
Bronchial tone: Resting bronchial constriction
Autonomic Integration
-
Baroreflex: Part of the baroreceptor reflex arc
-
Chemoreflex: Response to blood chemistry changes
-
Vagovagal reflexes: Gut-brain signaling
Role in Parkinson Disease
Early Pathological Involvement
The DMV is one of the first sites of alpha-synuclein pathology in PD, consistent with Braak staging:
-
Braak stages 1-2: Early involvement of DMV
-
Lewy neurites: Dendritic inclusions in DMV neurons
-
Lewy bodies: Cytoplasmic inclusions in cell bodies
-
Retrograde propagation: Pathology spreads via vagus nerve
Gut-Brain Axis Hypothesis
The DMV serves as a critical hub in the proposed gut-origin hypothesis of PD:
Gut (Enteric Nervous System) → Vagus nerve → DMV →
Dorsal raphe → Locus coeruleus → Substantia nigra → Cortex
This pathway explains:
-
Early GI symptoms: Constipation precedes motor symptoms by years
-
Initial brainstem involvement: Before substantia nigra
-
Non-motor symptoms: Autonomic dysfunction early in disease
Autonomic Dysfunction in PD
Mechanisms of Dysfunction
1. Alpha-Synuclein Pathology
-
Phosphorylated serine 129: Pathological form in DMV
-
Neuronal loss: 30-50% reduction in DMV neurons
-
Axonal degeneration: Vagal nerve fiber loss
-
Transsynaptic spread: Cell-to-cell propagation
2. Neuroinflammation
-
Microglial activation: In DMV region
-
Cytokine release: IL-1β, TNF-α, IL-6
-
Oxidative stress: ROS accumulation
-
Complement activation: Glial involvement
3. Neurotransmitter Changes
-
Cholinergic deficiency: Reduced acetylcholine
-
Noradrenergic loss: Locus coeruleus connection
-
Serotonergic dysfunction: Dorsal raphe involvement
Clinical Implications
Diagnostic Potential
-
Early biomarker: GI symptoms precede motor signs
-
Skin biopsy: Detection of peripheral alpha-syn
-
Colonoscopy samples: Enteric nervous system pathology
Therapeutic Implications
Gut-Based Therapeutic Strategies
-
Probiotics: Modulate gut microbiome
-
Fecal microbiota transplantation: Experimental
-
Anti-alpha-synuclein antibodies: Peripheral clearance
Animal Models
Cross-Links
Background
The study of Dorsal Motor Nucleus Of Vagus In Parkinson Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
External Links
-
PubMed - Biomedical literature
-
Alzheimer’s Disease Neuroimaging Initiative - Research data
-
Allen Brain Atlas - Brain gene expression data
Pathway Diagram
graph TD
Parkinson["Parkinson"] -->|"associated with"| Aging["Aging"]
Parkinson["Parkinson"] -->|"associated with"| Autophagy["Autophagy"]
Parkinson["Parkinson"] -->|"associated with"| Als["Als"]
Parkinson["Parkinson"] -->|"therapeutic target"| Blood_Brain_Barrier["Blood-Brain Barrier"]
Parkinson["Parkinson"] -->|"associated with"| Multiple_Sclerosis["Multiple Sclerosis"]
Parkinson["Parkinson"] -->|"associated with"| Oxidative_Stress["Oxidative Stress"]
Parkinson["Parkinson"] -->|"associated with"| Alzheimer["Alzheimer"]
Parkinson["Parkinson"] -->|"associated with"| Apoptosis["Apoptosis"]
Parkinson["Parkinson"] -->|"associated with"| Neurodegeneration["Neurodegeneration"]
Parkinson["Parkinson"] -->|"therapeutic target"| Oxidative_Stress["Oxidative Stress"]
Parkinson["Parkinson"] -->|"associated with"| Dementia["Dementia"]
Parkinson["Parkinson"] -->|"therapeutic target"| Autophagy["Autophagy"]
style Parkinson fill:#ef5350,stroke:#333,color:#e0e0e0
style Aging fill:#ef5350,stroke:#333,color:#e0e0e0
style Autophagy fill:#1b5e20,stroke:#333,color:#e0e0e0
style Als fill:#ef5350,stroke:#333,color:#e0e0e0
style Blood_Brain_Barrier fill:#1b5e20,stroke:#333,color:#e0e0e0
style Multiple_Sclerosis fill:#ef5350,stroke:#333,color:#e0e0e0
style Oxidative_Stress fill:#1b5e20,stroke:#333,color:#e0e0e0
style Alzheimer fill:#ef5350,stroke:#333,color:#e0e0e0
style Apoptosis fill:#1b5e20,stroke:#333,color:#e0e0e0
style Neurodegeneration fill:#ef5350,stroke:#333,color:#e0e0e0
style Dementia fill:#ef5350,stroke:#333,color:#e0e0e0Pathway Diagram
The following diagram shows the key molecular relationships involving Dorsal Motor Nucleus of Vagus in Parkinson Disease discovered through SciDEX knowledge graph analysis:
graph TD
PINK1["PINK1"] -->|"activates"| Parkinson["Parkinson"]
NRF2["NRF2"] -->|"therapeutic target"| Parkinson["Parkinson"]
Huntington["Huntington"] -->|"associated with"| Parkinson["Parkinson"]
PTEN["PTEN"] -->|"activates"| Parkinson["Parkinson"]
PARKIN["PARKIN"] -->|"associated with"| Parkinson["Parkinson"]
DNA["DNA"] -->|"therapeutic target"| Parkinson["Parkinson"]
Cancer["Cancer"] -->|"associated with"| Parkinson["Parkinson"]
Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"] -->|"associated with"| Parkinson["Parkinson"]
GENES["GENES"] -->|"activates"| Parkinson["Parkinson"]
GENES["GENES"] -->|"therapeutic target"| Parkinson["Parkinson"]
NRF2["NRF2"] -->|"activates"| Parkinson["Parkinson"]
GENES["GENES"] -->|"regulates"| Parkinson["Parkinson"]
Neuroinflammation["Neuroinflammation"] -->|"associated with"| Parkinson["Parkinson"]
GENES["GENES"] -->|"associated with"| Parkinson["Parkinson"]
PINK1["PINK1"] -->|"regulates"| Parkinson["Parkinson"]
style PINK1 fill:#ce93d8,stroke:#333,color:#000
style Parkinson fill:#ef5350,stroke:#333,color:#000
style NRF2 fill:#ce93d8,stroke:#333,color:#000
style Huntington fill:#ef5350,stroke:#333,color:#000
style PTEN fill:#ce93d8,stroke:#333,color:#000
style PARKIN fill:#ce93d8,stroke:#333,color:#000
style DNA fill:#ce93d8,stroke:#333,color:#000
style Cancer fill:#ef5350,stroke:#333,color:#000
style Amyotrophic_Lateral_Sclerosis fill:#ef5350,stroke:#333,color:#000
style GENES fill:#ce93d8,stroke:#333,color:#000
style Neuroinflammation fill:#ef5350,stroke:#333,color:#000References
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.